CYTOSORBENTS CORPORATION (CTSO) Revenue 2016–2025
CYTOSORBENTS CORPORATION (CTSO) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$37.1MFY2025 · since FY2016: $9.5M → $37.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $37.1M | +4.1% |
| FY2024 | $35.6M | +14.5% |
| FY2023 | $31.1M | -10.4% |
| FY2022 | $34.7M | -19.6% |
| FY2021 | $43.2M | +5.3% |
| FY2020 | $41.0M | +64.4% |
| FY2019 | $24.9M | +10.9% |
| FY2018 | $22.5M | +48.5% |
| FY2017 | $15.2M | +59.0% |
| FY2016 | $9.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice